Which patients do benefit? How to select and for which benefit?

Date 21 October 2018
Event ESMO 2018 Congress
Session ESMO COLLOQUIUM - Immune check point inhibitors: Are we ready for combination?
Topics Personalised/Precision Medicine
Presenter John Haanen
Authors J.B.A.G. Haanen
  • Medical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, 1066 CX - Amsterdam/NL

This educational colloquium is provided by ESMO and supported by Celgene.
View the ESMO colloquium details